M&A Deal Summary

Thermo Fisher Scientific Acquires Novasep s Viral Vector Manufacturing Business

On January 15, 2021, Thermo Fisher Scientific acquired manufacturer Novasep s Viral Vector Manufacturing Business from Novasep for 725M EUR

Acquisition Highlights
  • This is Thermo Fisher Scientific’s 2nd transaction in the Manufacturing sector.
  • This is Thermo Fisher Scientific’s 16th largest (disclosed) transaction.
  • This is Thermo Fisher Scientific’s 1st transaction in Belgium.

M&A Deal Summary

Date 2021-01-15
Target Novasep s Viral Vector Manufacturing Business
Sector Manufacturing
Buyer(s) Thermo Fisher Scientific
Sellers(s) Novasep
Deal Type Divestiture
Deal Value 725M EUR

Target

Novasep s Viral Vector Manufacturing Business

Seneffe, Belgium
Novasep's Viral Vector Manufacturing Business provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers. With two locations in Seneffe and Gosselies, Belgium, Novasep's viral vector business offers more than 7,000 square meters of state-of-the-art clinical and commercial manufacturing capacity.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Thermo Fisher Scientific

Waltham, Massachusetts, United States

Category Company
Founded 1956
Sector Test/Measurement Equipment
Employees122,000
Revenue 42.9B USD (2024)
DESCRIPTION
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.

Thermo Scientific provides analytical instruments, laboratory equipment, software, services, consumables and reagents for better workflow solutions spanning sample preparation, sample analysis, and data interpretation. Thermo Fisher Scientific was founded in 1956 and is based in Waltham, Massachusetts.


DEAL STATS #
Overall 55 of 65
Sector: Manufacturing M&A 2 of 2
Type: Divestiture M&A Deals 6 of 8
Country: Belgium M&A 1 of 1
Year: 2021 M&A 1 of 4
Size (of disclosed) 16 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-31 Phitonex

Durham, North Carolina, United States

Phitonex, Inc. is a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex was founded in 2017 and is based in Durham, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-19 Mesa Biotech

San Diego, California, United States

Mesa Biotech, Inc. is molecular diagnostic company develops and commercialize a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Mesa Biotech is based in San Diego, California.

Buy $450M

Seller(S) 1

SELLER

Novasep

Lyon, France

Category Company
Sector Life Science
Revenue 294M EUR (2007)
DESCRIPTION

Novasep provides cost-effective solutions for the sustainable production of molecules for the life sciences. Novasep offers a comprehensive range of services including process development, turnkey purification systems and contract manufacturing. The company specializes in challenging active molecules for pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients, as well as fermentation and chemical commodities industries. Novasep is based in Lyon, France.


DEAL STATS #
Overall 2 of 2
Sector: Manufacturing M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
Country: Belgium M&A 1 of 1
Year: 2021 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-06 Chromatography Process Equipment Division

Pompey, France

Chromatography Process Equipment Division provides resin-based batch and intensified chromatography systems, and primarily focuses on high-pressure, multi-use applications for smaller molecules, such as oligonucleotides, peptides, and insulin.

Sell -